Skip to main content
Top
Published in: Substance Abuse Treatment, Prevention, and Policy 1/2017

Open Access 01-12-2017 | Review

Zonnic®: a new player in an old field

Authors: Min Gong, Michael S. Dunbar, Claude Setodji, William G. Shadel

Published in: Substance Abuse Treatment, Prevention, and Policy | Issue 1/2017

Login to get access

Abstract

The tobacco industry is continually evolving to adapt to increasing tobacco control pressure and regulation, and to cater to consumer preferences. Recently, RJ Reynolds rolled-out a nicotine-containing gum, Zonnic®, which is marketed as a smoking cessation and reduction product and is sold at convenience stores at a lower price and in a smaller quantity than existing brands sold at pharmacies. The introduction of Zonnic® products is a critical first step in tobacco industry’s involvement in the NRT market and a serious indication of the evolving tobacco and nicotine-delivery industry and environment. It is likely that this trend will continue and spread, and as such, have a significant impact at multiple dimensions, including consumer perceptions and behavior, tobacco and NRT industry business strategy, and regulation and policy. In this special communication, we present an overview of the current marketing strategy for Zonnic®, discuss its potential impacts at the market level and at the level of the individual consumer, and suggest research and policy priorities based on the magnitude and urgency of the impacts.
Literature
1.
go back to reference Bialous SA, Peeters S. A brief overview of the tobacco industry in the last 20 years. Tob Control. 2012;21(2):92–4.CrossRef Bialous SA, Peeters S. A brief overview of the tobacco industry in the last 20 years. Tob Control. 2012;21(2):92–4.CrossRef
2.
3.
go back to reference Gilmore AB. Understanding the vector in order to plan effective tobacco control policies: an analysis of contemporary tobacco industry materials. Tob Control. 2012;21(2):119–26. Gilmore AB. Understanding the vector in order to plan effective tobacco control policies: an analysis of contemporary tobacco industry materials. Tob Control. 2012;21(2):119–26.
4.
go back to reference McNeill A, Hammond D, Gartner C. Whither tobacco product regulation? Tob Control. 2012;21(2):221–6.CrossRefPubMed McNeill A, Hammond D, Gartner C. Whither tobacco product regulation? Tob Control. 2012;21(2):221–6.CrossRefPubMed
7.
go back to reference Kostygina G, England L, Ling P. New product marketing blurs the line between nicotine replacement therapy and smokeless tobacco products. Am J Public Health. 2016;106(7):1219–22.CrossRefPubMedPubMedCentral Kostygina G, England L, Ling P. New product marketing blurs the line between nicotine replacement therapy and smokeless tobacco products. Am J Public Health. 2016;106(7):1219–22.CrossRefPubMedPubMedCentral
8.
go back to reference McCarthy EJ. Basic marketing: A managerial approach. Homewood, IL. RD Irwin; 1978. McCarthy EJ. Basic marketing: A managerial approach. Homewood, IL. RD Irwin; 1978.
10.
go back to reference Dowling GR. The art and science of marketing: marketing for marketing managers. USA: Oxford University Press; 2004.CrossRef Dowling GR. The art and science of marketing: marketing for marketing managers. USA: Oxford University Press; 2004.CrossRef
13.
go back to reference Moore D, et al. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ. 2009;338:b1024.CrossRefPubMedPubMedCentral Moore D, et al. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ. 2009;338:b1024.CrossRefPubMedPubMedCentral
14.
go back to reference Vogt F, Hall S, Marteau TM. Understanding why smokers do not want to use nicotine dependence medications to stop smoking: qualitative and quantitative studies. Nicotine Tob Res. 2008;10(8):1405–13.CrossRefPubMed Vogt F, Hall S, Marteau TM. Understanding why smokers do not want to use nicotine dependence medications to stop smoking: qualitative and quantitative studies. Nicotine Tob Res. 2008;10(8):1405–13.CrossRefPubMed
15.
go back to reference Shiffman S, et al. Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance. Addiction. 2008;103(8):1371–8.CrossRefPubMed Shiffman S, et al. Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance. Addiction. 2008;103(8):1371–8.CrossRefPubMed
16.
go back to reference Lindson N, Aveyard P, Hughes JR. Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database Syst Rev. 2012;11:CD008033. Lindson N, Aveyard P, Hughes JR. Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database Syst Rev. 2012;11:CD008033.
17.
go back to reference Lindson-Hawley N, et al. Gradual versus abrupt smoking cessation. Ann Intern Med. 2016;164:585–92.CrossRefPubMed Lindson-Hawley N, et al. Gradual versus abrupt smoking cessation. Ann Intern Med. 2016;164:585–92.CrossRefPubMed
18.
go back to reference Silagy C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004;3:CD000146. Silagy C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004;3:CD000146.
19.
go back to reference Federal Trade Commission. Cigarette report, 2012. Washington, DC: FTC; 2015. Federal Trade Commission. Cigarette report, 2012. Washington, DC: FTC; 2015.
23.
go back to reference Henriksen L, et al. Effects on youth of exposure to retail tobacco advertising1. J Appl Soc Psychol. 2002;32(9):1771–89.CrossRef Henriksen L, et al. Effects on youth of exposure to retail tobacco advertising1. J Appl Soc Psychol. 2002;32(9):1771–89.CrossRef
24.
go back to reference Kim AE, et al. Influence of tobacco displays and ads on youth: a virtual store experiment. Pediatrics. 2013;131(1):e88–95.CrossRefPubMed Kim AE, et al. Influence of tobacco displays and ads on youth: a virtual store experiment. Pediatrics. 2013;131(1):e88–95.CrossRefPubMed
25.
go back to reference Shadel WG, et al. Hiding the tobacco power wall reduces cigarette smoking risk in adolescents: using an experimental convenience store to assess tobacco regulatory options at retail point-of-sale. Tob Control. 2016;25:679-84. Shadel WG, et al. Hiding the tobacco power wall reduces cigarette smoking risk in adolescents: using an experimental convenience store to assess tobacco regulatory options at retail point-of-sale. Tob Control. 2016;25:679-84.
26.
go back to reference Wakefield M, et al. An experimental study of effects on schoolchildren of exposure to point-of-sale cigarette advertising and pack displays. Health Educ Res. 2006;21(3):338–47.CrossRefPubMed Wakefield M, et al. An experimental study of effects on schoolchildren of exposure to point-of-sale cigarette advertising and pack displays. Health Educ Res. 2006;21(3):338–47.CrossRefPubMed
27.
go back to reference Nan X, Faber RJ. Advertising theory: Reconceptualizing the building blocks. Mark Theory. 2004;4(1-2):7–30.CrossRef Nan X, Faber RJ. Advertising theory: Reconceptualizing the building blocks. Mark Theory. 2004;4(1-2):7–30.CrossRef
29.
go back to reference Carter SM. From legitimate consumers to public relations pawns: the tobacco industry and young Australians. Tob Control. 2003;12(suppl 3):iii71–8.PubMedPubMedCentral Carter SM. From legitimate consumers to public relations pawns: the tobacco industry and young Australians. Tob Control. 2003;12(suppl 3):iii71–8.PubMedPubMedCentral
30.
go back to reference Landman A, Ling PM, Glantz SA. Tobacco industry youth smoking prevention programs: protecting the industry and hurting tobacco control. Am J Public Health. 2002;92(6):917–30.CrossRefPubMedPubMedCentral Landman A, Ling PM, Glantz SA. Tobacco industry youth smoking prevention programs: protecting the industry and hurting tobacco control. Am J Public Health. 2002;92(6):917–30.CrossRefPubMedPubMedCentral
36.
go back to reference O’Loughlin J, Wellman RJ, Potvin L. Whither the e-cigarette? Int J Public Health. 2016;61(2):147–8.CrossRefPubMed O’Loughlin J, Wellman RJ, Potvin L. Whither the e-cigarette? Int J Public Health. 2016;61(2):147–8.CrossRefPubMed
Metadata
Title
Zonnic®: a new player in an old field
Authors
Min Gong
Michael S. Dunbar
Claude Setodji
William G. Shadel
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Substance Abuse Treatment, Prevention, and Policy / Issue 1/2017
Electronic ISSN: 1747-597X
DOI
https://doi.org/10.1186/s13011-017-0124-3

Other articles of this Issue 1/2017

Substance Abuse Treatment, Prevention, and Policy 1/2017 Go to the issue